Unusual Benign and Malignant Neoplasms of Lung: Molecular Pathology

  • Dongfeng Tan
  • Guoping Wang
  • Sadir Alrawi
Part of the Molecular Pathology Library book series (MPLB, volume 1)


Pulmonary sclerosing hemangioma is a unique lung neoplasm. It occurs sporadically in middle-aged patients, although cases have been reported in the pediatric population and may be associated with familial adenomatous polyposis.1,2 Sclerosing hemangiomas are typically peripheral and involve lung parenchyma. However, they rarely present as endobronchial polypoid masses resulting in clinical symptoms of bronchial obstruction.3 The lesions have sclerosis and hemorrhagic cystic spaces lined by surface/cuboidal cells thought to be reactive and solid areas consisting of round/polygonal cells thought to be neoplastic. For many years sclerosing hemangioma was thought to be a vascular tumor because of its microscopic appearance, hence the name.


Tuberous Sclerosis Complex Glomus Tumor Myxoid Liposarcomas Sarcoma Alveolar Soft Part Cartilaginous Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Batinica S, Gunek G, Raos M, et al. Sclerosing haemangioma of the lung in a 4-year-old child. Eur J Pediatr Surg 2002;12(3):192–194.CrossRefPubMedGoogle Scholar
  2. 2.
    Hosaka N, Sasaki T, Adachi K, et al. Pulmonary sclerosing hemangioma associated with familial adenomatous polyposis. Hum Pathol 2004;35(6):764–768.CrossRefPubMedGoogle Scholar
  3. 3.
    Devouassoux-Shisheboran M, de la Fouchardiere A, Thivolet-Bejui F, et al. Endobronchial variant of sclerosing hemangioma of the lung: histological and cytological features on endobronchial material. Mod Pathol 2004;17(2):252–257.CrossRefPubMedGoogle Scholar
  4. 4.
    Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, et al. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol 2000;24(7):906–916.CrossRefPubMedGoogle Scholar
  5. 5.
    Yamazaki K. Type-II pneumocyte differentiation in pulmonary sclerosing hemangioma: ultrastructural differentiation and immunohistochemical distribution of lineage-specific transcription factors (TTF-1, HNF-3 alpha, and HNF-3 beta) and surfactant proteins. Virchows Arch 2004;445(1):45–53.PubMedGoogle Scholar
  6. 6.
    Wang E, Lin D, Wang Y, et al. Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma. Hum Pathol 2004;35(4):503–508.CrossRefPubMedGoogle Scholar
  7. 7.
    Dacic S, Sasatomi E, Swalsky PA, et al. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis. Arch Pathol Lab Med 2004;128(8):880–884.PubMedGoogle Scholar
  8. 8.
    Wu CT, Chang YL, Lee YC. Expression of the estrogen receptor beta in 37 surgically treated pulmonary sclerosing hemangiomas in comparison with non-small cell lung carcinomas. Hum Pathol 2005;36(10):1108–1112.CrossRefPubMedGoogle Scholar
  9. 9.
    Steagall WK, Taveira-DaSilva AM, Moss J. Clinical and molecular insights into lymphangioleiomyomatosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22(Suppl 1):S49–S66.PubMedGoogle Scholar
  10. 10.
    Cagnano M, Benharroch D, Geffen DB. Pulmonary lymphangioleiomyomatosis. Report of a case with associated multiple soft-tissue tumors. Arch Pathol Lab Med 1991;115(12):1257–1259.PubMedGoogle Scholar
  11. 11.
    Goncharova EA, Goncharov DA, Spaits M, et al. Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: role for tumor suppressor TSC2. Am J Respir Cell Mol Biol 2006;34(5):561–572.CrossRefPubMedGoogle Scholar
  12. 12.
    Patsios D, Hwang DM, Chung TB. Intraparenchymal solitary fibrous tumor of the lung: an uncommon cause of a pulmonary nodule. J Thorac Imaging 2006;21(1):50–53.CrossRefPubMedGoogle Scholar
  13. 13.
    Jha V, Gil J, Teirstein AS. Familial solitary fibrous tumor of the pleura: a case report. Chest 2005;127(5):1852–1854.CrossRefPubMedGoogle Scholar
  14. 14.
    Tagliabue F, Vertemati G, Confalonieri G, et al. Benign solitary fibrous tumour of the pleura: a clinical review and report of six cases. Chir Ital 2005;57(5):649–653.PubMedGoogle Scholar
  15. 15.
    Morimitsu Y, Nakajima M, Hisaoka M, Hashimoto H. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway. APMIS 2000;108(9):617–625.CrossRefPubMedGoogle Scholar
  16. 16.
    Kanamori Y, Hashizume K, Sugiyama M, et al. Intrapulmonary solitary fibrous tumor in an eight-year-old male. Pediatr Pulmonol 2005;40(3):261–264.CrossRefPubMedGoogle Scholar
  17. 17.
    Miettinen MM, el-Rifai W, Sarlomo-Rikala M, et al. Tumor size-related DNA copy number changes occur in solitary fibrous tumors but not in hemangiopericytomas. Mod Pathol 1997;10(12):1194–1200.PubMedGoogle Scholar
  18. 18.
    Debiec-Rychter M, de Wever I, Hagemeijer A, Sciot R. Is 4q13 a recurring breakpoint in solitary fibrous tumors? Cancer Genet Cytogenet 2001;131(1):69–73.CrossRefPubMedGoogle Scholar
  19. 19.
    Dal Cin P, Sciot R, Fletcher CD, et al. Trisomy 21 in solitary fibrous tumor. Cancer Genet Cytogenet 1996;86(1):58–60.CrossRefGoogle Scholar
  20. 20.
    Travis WD, Churg A, Aubry MC, Ordonez NG. Mesenchymal tumors. In Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004:141–144.Google Scholar
  21. 21.
    Willen H, Akerman M, Dal Cin P, et al. Comparison of chromosomal patterns with clinical features in 165 lipomas: a report of the CHAMP study group. Cancer Genet Cytogenet 1998;102(1):46–49.CrossRefPubMedGoogle Scholar
  22. 22.
    Nilsson M, Mertens F, Hoglund M, et al. Truncation and fusion of HMGA2 in lipomas with rearrangements of 5q32→q33 and 12q14→q15. Cytogenet Genome Res 2006;112(1–2):60–66.CrossRefPubMedGoogle Scholar
  23. 23.
    Aman P, Ron D, Mandahl N, et al. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer 1992;5(4):278–285.CrossRefPubMedGoogle Scholar
  24. 24.
    Yousem SA, Tazelaar HD, Manabe T, Dehner LP. Inflammatory myofibroblastic tumor. In Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004:105–106.Google Scholar
  25. 25.
    Panagopoulos I, Mertens F, Isaksson M, et al. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 2002;35(4):340–352.CrossRefPubMedGoogle Scholar
  26. 26.
    Bridge JA, Bhatia PS, Anderson JR, Neff JR. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet 1993;69(2):79–90.CrossRefPubMedGoogle Scholar
  27. 27.
    Ozaki T, Wai D, Schafer KL, et al. Comparative genomic hybridization in cartilaginous tumors. Anticancer Res 2004;24(3a):1721–1725.PubMedGoogle Scholar
  28. 28.
    Vikkula M, Boon LM, Mulliken JB. Molecular genetics of vascular malformations. Matrix Biol 2001;20(5–6):327–335.CrossRefPubMedGoogle Scholar
  29. 29.
    Boon LM, Brouillard P, Irrthum A, et al. A gene for inherited cutaneous venous anomalies (“glomangiomas”) localizes to chromosome 1p21–22. Am J Hum Genet 1999;65(1):125–133.CrossRefPubMedGoogle Scholar
  30. 30.
    Miettinen M, Paal E, Lasota J, Sobin LH. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol 2002;26(3):301–311.CrossRefPubMedGoogle Scholar
  31. 31.
    Essary LR, Vargas SO, Fletcher CD. Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset. Cancer 2002;94:459–469.CrossRefPubMedGoogle Scholar
  32. 32.
    Yi JE, Tazelaar HD, Burke A, Manabe T. Pulmonary artery sarcoma. In Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004:109–110.Google Scholar
  33. 33.
    Saito T, Oda Y, Kawaguchi K, et al. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma. Hum Pathol 2003;34(9):841–849.CrossRefPubMedGoogle Scholar
  34. 34.
    Ladanyi M, Antonescu CR, Drobnjak M, et al. The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147. Am J Pathol 2002;160(4):1215–1221.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Dongfeng Tan
    • 1
  • Guoping Wang
    • 2
  • Sadir Alrawi
    • 3
  1. 1.Department of PathologyUniversity of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Department of Pathology, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  3. 3.Department of SurgeryUniversity of FloridaJacksonvilleUSA

Personalised recommendations